1. Home
  2. OFAL vs ZYXI Comparison

OFAL vs ZYXI Comparison

Compare OFAL & ZYXI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OFAL
  • ZYXI
  • Stock Information
  • Founded
  • OFAL 2013
  • ZYXI 1996
  • Country
  • OFAL Hong Kong
  • ZYXI United States
  • Employees
  • OFAL N/A
  • ZYXI N/A
  • Industry
  • OFAL Military/Government/Technical
  • ZYXI Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • OFAL Consumer Discretionary
  • ZYXI Health Care
  • Exchange
  • OFAL Nasdaq
  • ZYXI Nasdaq
  • Market Cap
  • OFAL 62.1M
  • ZYXI 66.5M
  • IPO Year
  • OFAL 2025
  • ZYXI N/A
  • Fundamental
  • Price
  • OFAL $5.06
  • ZYXI $2.11
  • Analyst Decision
  • OFAL
  • ZYXI Buy
  • Analyst Count
  • OFAL 0
  • ZYXI 3
  • Target Price
  • OFAL N/A
  • ZYXI $6.00
  • AVG Volume (30 Days)
  • OFAL 2.6M
  • ZYXI 192.3K
  • Earning Date
  • OFAL 01-01-0001
  • ZYXI 07-24-2025
  • Dividend Yield
  • OFAL N/A
  • ZYXI N/A
  • EPS Growth
  • OFAL N/A
  • ZYXI N/A
  • EPS
  • OFAL N/A
  • ZYXI N/A
  • Revenue
  • OFAL $386,355.00
  • ZYXI $172,401,000.00
  • Revenue This Year
  • OFAL N/A
  • ZYXI N/A
  • Revenue Next Year
  • OFAL N/A
  • ZYXI $19.55
  • P/E Ratio
  • OFAL N/A
  • ZYXI N/A
  • Revenue Growth
  • OFAL N/A
  • ZYXI N/A
  • 52 Week Low
  • OFAL $3.75
  • ZYXI $1.66
  • 52 Week High
  • OFAL $9.79
  • ZYXI $10.62
  • Technical
  • Relative Strength Index (RSI)
  • OFAL N/A
  • ZYXI 41.54
  • Support Level
  • OFAL N/A
  • ZYXI $2.21
  • Resistance Level
  • OFAL N/A
  • ZYXI $2.66
  • Average True Range (ATR)
  • OFAL 0.00
  • ZYXI 0.20
  • MACD
  • OFAL 0.00
  • ZYXI 0.00
  • Stochastic Oscillator
  • OFAL 0.00
  • ZYXI 9.10

About ZYXI Zynex Inc.

Zynex Inc is engaged in the manufacturing and marketing of medical devices. It operates through one primary business segment, Electrotherapy and Pain Management Products. The business activities of the company are carried out through its subsidiaries. The company designs, manufactures, and markets medical devices that treat chronic and acute pain, as well as activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company operates business as one operating segment which includes two revenue types: Devices and Supplies. Its markets Zynex-manufactured products which include NexWave, NeuroMove, InWave E-Wave, and others.

Share on Social Networks: